
Brand Name | Status | Last Update |
|---|---|---|
| aminosyn ii | New Drug Application | 2022-05-04 |
| aminosyn-pf | New Drug Application | 2022-07-21 |
| asce plus derma signal kit srlv | unapproved drug other | 2021-11-23 |
| clinimix | New Drug Application | 2021-04-13 |
| clinimix e | New Drug Application | 2021-04-13 |
| clinisol | ANDA | 2018-06-01 |
| exoscrt derma signal kit srlv | unapproved drug other | 2021-11-23 |
| exoscrt derma signal srlv vial 1. lyophilized | unapproved drug other | 2024-12-09 |
| exoscrt derma signal srlv vial 2. diluent | unapproved drug other | 2024-12-09 |
| ilevro | New Drug Application | 2025-07-16 |

Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Head and neck neoplasms | D006258 | — | — | 1 | 1 | — | — | — | 1 |
| Drug common name | Isoleucine |
| INN | isoleucine |
| Description | 2-amino-3-methylpentanoic acid is a branched chain amino acid that consists of 3-methylpentanoic acid bearing an amino substituent at position 2. It is an alpha-amino acid and a branched-chain amino acid. |
| Classification | Small molecule |
| Drug class | — |
| Image (chem structure or protein) | ![]() |
| Structure (InChI/SMILES or Protein Sequence) | CC[C@H](C)[C@H](N)C(=O)O |
| PDB | — |
| CAS-ID | 73-32-5 |
| RxCUI | — |
| ChEMBL ID | CHEMBL1233584 |
| ChEBI ID | 17191 |
| PubChem CID | 791 |
| DrugBank | DB00167 |
| UNII ID | 04Y7590D77 (ChemIDplus, GSRS) |

